These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35757692)

  • 61. Leishmania vaccine development: exploiting the host-vector-parasite interface.
    Reed SG; Coler RN; Mondal D; Kamhawi S; Valenzuela JG
    Expert Rev Vaccines; 2016; 15(1):81-90. PubMed ID: 26595093
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sand fly specificity of saliva-mediated protective immunity in Leishmania amazonensis-BALB/c mouse model.
    Thiakaki M; Rohousova I; Volfova V; Volf P; Chang KP; Soteriadou K
    Microbes Infect; 2005 Apr; 7(4):760-6. PubMed ID: 15866511
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunization with LJM11 salivary protein protects against infection with Leishmania braziliensis in the presence of Lutzomyia longipalpis saliva.
    Cunha JM; Abbehusen M; Suarez M; Valenzuela J; Teixeira CR; Brodskyn CI
    Acta Trop; 2018 Jan; 177():164-170. PubMed ID: 29037520
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detection of Leishmania tarentolae in lizards, sand flies and dogs in southern Italy, where Leishmania infantum is endemic: hindrances and opportunities.
    Mendoza-Roldan JA; Latrofa MS; Iatta R; R S Manoj R; Panarese R; Annoscia G; Pombi M; Zatelli A; Beugnet F; Otranto D
    Parasit Vectors; 2021 Sep; 14(1):461. PubMed ID: 34493323
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analysis of salivary gland transcripts of the sand fly Lutzomyia ayacuchensis, a vector of Andean-type cutaneous leishmaniasis.
    Kato H; Jochim RC; Gomez EA; Uezato H; Mimori T; Korenaga M; Sakurai T; Katakura K; Valenzuela JG; Hashiguchi Y
    Infect Genet Evol; 2013 Jan; 13():56-66. PubMed ID: 23000112
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana.
    Dey R; Natarajan G; Bhattacharya P; Cummings H; Dagur PK; Terrazas C; Selvapandiyan A; McCoy JP; Duncan R; Satoskar AR; Nakhasi HL
    J Immunol; 2014 Oct; 193(7):3513-27. PubMed ID: 25156362
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11.
    Santos DM; Carneiro MW; de Moura TR; Fukutani K; Clarencio J; Soto M; Espuelas S; Brodskyn C; Barral A; Barral-Netto M; de Oliveira CI
    Int J Nanomedicine; 2012; 7():2115-27. PubMed ID: 22619548
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cutaneous leishmaniasis in the central provinces of Hama and Edlib in Syria: Vector identification and parasite typing.
    Haddad N; Saliba H; Altawil A; Villinsky J; Al-Nahhas S
    Parasit Vectors; 2015 Oct; 8():524. PubMed ID: 26459055
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites.
    Badirzadeh A; Taheri T; Taslimi Y; Abdossamadi Z; Heidari-Kharaji M; Gholami E; Sedaghat B; Niyyati M; Rafati S
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005774. PubMed ID: 28708893
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.
    Rostamian M; Bahrami F; Niknam HM
    PLoS One; 2018; 13(9):e0204491. PubMed ID: 30248142
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A non-pathogenic Leishmania tarentolae vector based- HCV polytope DNA vaccine elicits potent and long lasting Th1 and CTL responses in BALB/c mice model.
    Ansari N; Rafati S; Taheri T; Roohvand F; Farahmand M; Hajikhezri Z; Keshavarz A; Samimi-Rad K
    Mol Immunol; 2019 Jul; 111():152-161. PubMed ID: 31054409
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cross-protective efficacy of Leishmania infantum LiHyD protein against tegumentary leishmaniasis caused by Leishmania major and Leishmania braziliensis species.
    Lage DP; Martins VT; Duarte MC; Costa LE; Tavares GSV; Ramos FF; Chávez-Fumagalli MA; Menezes-Souza D; Roatt BM; Tavares CAP; Coelho EAF
    Acta Trop; 2016 Jun; 158():220-230. PubMed ID: 26976272
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Protective immunity against Leishmania major induced by Leishmania tropica infection of BALB/c mice.
    Mahmoudzadeh-Niknam H; Kiaei SS; Iravani D
    Exp Parasitol; 2011 Feb; 127(2):448-53. PubMed ID: 21035446
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative Evolution of Sand Fly Salivary Protein Families and Implications for Biomarkers of Vector Exposure and Salivary Vaccine Candidates.
    Coutinho-Abreu IV; Valenzuela JG
    Front Cell Infect Microbiol; 2018; 8():290. PubMed ID: 30211125
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity.
    Saini S; Ghosh AK; Das S; Singh R; Abhishek K; Verma S; Kumar A; Mandal A; Purkait B; Sinha KK; Das P
    Vaccine; 2018 Feb; 36(9):1190-1202. PubMed ID: 29395522
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunity to LuloHya and Lundep, the salivary spreading factors from Lutzomyia longipalpis, protects against Leishmania major infection.
    Martin-Martin I; Chagas AC; Guimaraes-Costa AB; Amo L; Oliveira F; Moore IN; DeSouza-Vieira TS; Sanchez EE; Suntravat M; Valenzuela JG; Ribeiro JMC; Calvo E
    PLoS Pathog; 2018 May; 14(5):e1007006. PubMed ID: 29723281
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The immune response to sand fly salivary proteins and its influence on leishmania immunity.
    Gomes R; Oliveira F
    Front Immunol; 2012; 3():110. PubMed ID: 22593758
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival.
    Rogers M; Kropf P; Choi BS; Dillon R; Podinovskaia M; Bates P; Müller I
    PLoS Pathog; 2009 Aug; 5(8):e1000555. PubMed ID: 19696894
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia.
    Tavares NM; Silva RA; Costa DJ; Pitombo MA; Fukutani KF; Miranda JC; Valenzuela JG; Barral A; de Oliveira CI; Barral-Netto M; Brodskyn C
    PLoS Negl Trop Dis; 2011; 5(5):e1169. PubMed ID: 21655303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.